About Dolat Algotech Ltd
Dolat Algotech the Company is engaged in proprietary trading of shares, securities, commodities and other financial products and is not involved in manufacturing or selling of tangible products. Life Cycle Perspective/ Assessments (LCA) of products is not applicable.
Founded
1983
CEO
Harendra D Shah
Employees
143
HQ
Mumbai, India
Finished Products
1Income from Shares/Derivatives
₹355.53Cr2Traded Goods
₹287.35Cr3Interest
₹151.60Cr4Share of profit from partners
₹60.98Cr5Other Operating Revenue
₹41.78Cr6Dividends
₹17.61Cr7Income from Liquid Fund
₹4.84CrRaw Materials
No raw materials reported
This company hasn’t disclosed any raw materials breakdown.
About Dolat Algotech Ltd
Dolat Algotech the Company is engaged in proprietary trading of shares, securities, commodities and other financial products and is not involved in manufacturing or selling of tangible products. Life Cycle Perspective/ Assessments (LCA) of products is not applicable.
Founded:1983
CEO:Harendra D Shah
Employees:143
HQ:Mumbai, India
Finished Products
1Income from Shares/Derivatives
₹355.53Cr2Traded Goods
₹287.35Cr3Interest
₹151.60Cr4Share of profit from partners
₹60.98Cr5Other Operating Revenue
₹41.78Cr6Dividends
₹17.61Cr7Income from Liquid Fund
₹4.84CrRaw Materials
No raw materials reported
This company hasn’t disclosed any raw materials breakdown.
Price Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹96
52W Low
₹65
Volume178.49K
Avg VolumeN/A
Beta0.88
Dividend Yield0.14%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
8.49x
Valuation
P/B Ratio
1.08x
Valuation
EPS
₹8.20
Valuation
Dividend Yield
0.14%
Valuation
ROE
11.41%
Profitability
ROCE
15.93%
Profitability
Revenue by Segment
Contribution & growth by business line
Trading in shares and securitiesRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.25x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
23.8%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.